Meet QIAGEN at ESHG 2023

Our understanding of inherited genetic disorders is advancing, largely driven by whole exome sequencing (WES) and whole genome sequencing (WGS). However, implementing WES and WGS in research, clinical or translational settings remains challenging. Our panel of experts will present a series of short talks on how labs can overcome the barriers of WES/WGS implementation from pre-analytics to variant interpretation. Featured topics include non-invasive sample collection for population-scale WGS projects with a real-world use-case and how labs can improve efficiency and scalability in WES/WGS with an ultra-fast, automation-compatible sample-to-report workflow that can help reduce costs and turnaround time by 50% for the analytical and variant interpretation components. Plus, hear from a clinical geneticist on how her lab streamlines and accelerates NGS variant interpretation with a software solution that leverages augmented molecular intelligence (AMI).